Biolife Solutions Profit Margin

Biolife Solutions (BLFS) currently reports a profit margin of 49.06% as of June 2026. That compares with -7.23% in the prior-year period — up 778.8% year over year. That is above the Healthcare sector average of 13.76%. Use the charts on this page to explore Biolife Solutions's profit margin history and peer comparisons.

Biolife Solutions's profit margin increased from -7.23% to 49.06% — a 778.8% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Biolife Solutions's profit margin of 49.06% is higher than the Healthcare sector average of 13.76%. That is roughly 256.6% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Biolife Solutions's current 49.06% should be judged against Healthcare norms (sector average: 13.76%) and against BLFS's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 49.06%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.76%. From there, open related valuation or income-statement pages for Biolife Solutions, and consider following BLFS for alerts when major investors trade the stock.